Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261661 · ClinicalTrials.gov registry record · NA
Improving Response to Intervention in Students With or at Risk of Reading Disabilities
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 580
- Enrollment target
NCT03261661: Completed NA study, sponsored by Vanderbilt University.
NCT03261661 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 580 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03261661, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 580 participants
- Enrollment target
Study Summary
The purpose of the proposed studies is to examine a reading intervention for fourth grade students with reading difficulties that integrate work in mindset (beliefs about whether abilities are innate or can be developed) with the academic component of reading. Specifically, the investigators will examine the extent to which integrating mindset intervention improves student response to reading intervention. The investigators will use previous research in intensive reading intervention for students with reading difficulties in the upper elementary grades to examine an intervention that addresses reading skill deficits, while also providing mindset training along with (Study 1) or embedded in (Study 2) the reading intervention. It is hypothesized that students in the reading intervention with mindset conditions will improve their reading outcomes more than students in the reading intervention only and business as usual groups.
Primary Outcome
Students are instructed to read a short passage and identify a missing key word that would make sense
Interventions
- BEHAVIORAL Reading
- BEHAVIORAL Mindset
- BEHAVIORAL Reading Embedded with Mindset
- BEHAVIORAL Business as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2017-08-18 |
| Est. Completion | 2021-05-31 |
| Phase | NA |
What the finished NCT03261661 record still lists
NCT03261661 is an interventional study that assigns participants to a tested intervention. The registered 580 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 4 interventions - of which Reading is the first listed.
NCT03261661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03261661 about?
NCT03261661 is a clinical study titled "Improving Response to Intervention in Students With or at Risk of Reading Disabilities". The purpose of the proposed studies is to examine a reading intervention for fourth grade students with reading difficulties that integrate work in mindset (beliefs about whether abilities are innate or can be developed) with the academic component of reading. Specifically, the investigators will ex...
What is the current status of trial NCT03261661?
This trial is currently completed. It is a NA study. The enrollment target is 580 participants. The study started on 2017-08-18. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03261661?
The interventions under investigation include: Reading (BEHAVIORAL), Mindset (BEHAVIORAL), Reading Embedded with Mindset (BEHAVIORAL), Business as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT03261661?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03261661's enrollment target sits among peer trials
580 177th of 2000 higher than 1,824 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
- NCT06578104 · 580 participants
PULSED AF Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI